Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Analysis of Operating Leases

Microsoft Excel

Adjustments to Financial Statements for Operating Leases

Johnson & Johnson, adjustments to financial statements

US$ in millions

Microsoft Excel
Dec 28, 2025 Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Adjustment to Total Assets
Total assets (as reported) 199,210 180,104 167,558 187,378 182,018
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Total assets (adjusted) 199,210 180,104 167,558 187,378 182,018
Adjustment to Total Debt
Total debt (as reported) 47,933 36,634 29,332 39,659 33,751
Add: Operating lease liability (before adoption of FASB Topic 842)2
Add: Operating lease liability 1,400 1,200 1,100 1,300 1,000
Total debt (adjusted) 49,333 37,834 30,432 40,959 34,751

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1, 2 Equal to total present value of future operating lease payments.


Johnson & Johnson, Financial Data: Reported vs. Adjusted



Adjusted Financial Ratios for Operating Leases (Summary)

Johnson & Johnson, adjusted financial ratios

Microsoft Excel
Dec 28, 2025 Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Total Asset Turnover1
Reported total asset turnover 0.47 0.49 0.51 0.51 0.52
Adjusted total asset turnover 0.47 0.49 0.51 0.51 0.52
Debt to Equity2
Reported debt to equity 0.59 0.51 0.43 0.52 0.46
Adjusted debt to equity 0.60 0.53 0.44 0.53 0.47
Return on Assets3 (ROA)
Reported ROA 13.46% 7.81% 20.98% 9.57% 11.47%
Adjusted ROA 13.46% 7.81% 20.98% 9.57% 11.47%

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

Financial ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Johnson & Johnson adjusted total asset turnover ratio deteriorated from 2023 to 2024 and from 2024 to 2025.
Adjusted debt to equity A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity. Johnson & Johnson adjusted debt to equity ratio deteriorated from 2023 to 2024 and from 2024 to 2025.
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. Johnson & Johnson adjusted ROA deteriorated from 2023 to 2024 but then slightly improved from 2024 to 2025.

Johnson & Johnson, Financial Ratios: Reported vs. Adjusted



Adjusted Total Asset Turnover

Microsoft Excel
Dec 28, 2025 Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Sales to customers 94,193 88,821 85,159 94,943 93,775
Total assets 199,210 180,104 167,558 187,378 182,018
Activity Ratio
Total asset turnover1 0.47 0.49 0.51 0.51 0.52
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Sales to customers 94,193 88,821 85,159 94,943 93,775
Adjusted total assets 199,210 180,104 167,558 187,378 182,018
Activity Ratio
Adjusted total asset turnover2 0.47 0.49 0.51 0.51 0.52

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Total asset turnover = Sales to customers ÷ Total assets
= 94,193 ÷ 199,210 = 0.47

2 Adjusted total asset turnover = Sales to customers ÷ Adjusted total assets
= 94,193 ÷ 199,210 = 0.47

Activity ratio Description The company
Adjusted total asset turnover An activity ratio calculated as total revenue divided by adjusted total assets. Johnson & Johnson adjusted total asset turnover ratio deteriorated from 2023 to 2024 and from 2024 to 2025.


Adjusted Debt to Equity

Microsoft Excel
Dec 28, 2025 Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Total debt 47,933 36,634 29,332 39,659 33,751
Shareholders’ equity 81,544 71,490 68,774 76,804 74,023
Solvency Ratio
Debt to equity1 0.59 0.51 0.43 0.52 0.46
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Adjusted total debt 49,333 37,834 30,432 40,959 34,751
Shareholders’ equity 81,544 71,490 68,774 76,804 74,023
Solvency Ratio
Adjusted debt to equity2 0.60 0.53 0.44 0.53 0.47

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Debt to equity = Total debt ÷ Shareholders’ equity
= 47,933 ÷ 81,544 = 0.59

2 Adjusted debt to equity = Adjusted total debt ÷ Shareholders’ equity
= 49,333 ÷ 81,544 = 0.60

Solvency ratio Description The company
Adjusted debt-to-equity A solvency ratio calculated as adjusted total debt divided by total shareholders’ equity. Johnson & Johnson adjusted debt-to-equity ratio deteriorated from 2023 to 2024 and from 2024 to 2025.


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 28, 2025 Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Net earnings 26,804 14,066 35,153 17,941 20,878
Total assets 199,210 180,104 167,558 187,378 182,018
Profitability Ratio
ROA1 13.46% 7.81% 20.98% 9.57% 11.47%
Adjusted for Operating Leases
Selected Financial Data (US$ in millions)
Net earnings 26,804 14,066 35,153 17,941 20,878
Adjusted total assets 199,210 180,104 167,558 187,378 182,018
Profitability Ratio
Adjusted ROA2 13.46% 7.81% 20.98% 9.57% 11.47%

Based on: 10-K (reporting date: 2025-12-28), 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 ROA = 100 × Net earnings ÷ Total assets
= 100 × 26,804 ÷ 199,210 = 13.46%

2 Adjusted ROA = 100 × Net earnings ÷ Adjusted total assets
= 100 × 26,804 ÷ 199,210 = 13.46%

Profitability ratio Description The company
Adjusted ROA A profitability ratio calculated as net income divided by adjusted total assets. Johnson & Johnson adjusted ROA deteriorated from 2023 to 2024 but then slightly improved from 2024 to 2025.